Profile avatar
blakeformansci.bsky.social
Senior Science Writer at Technology Networks | Science communicator | Covering breaking science news | All views my own #SciComm https://www.technologynetworks.com/tn/editor/blake-forman
9 posts 8 followers 5 following
Getting Started
Posts 8 Comments 1

After two years the FDA has lifted the clinical hold on Entrada Therapeutics Duchenne muscular dystrophy (DMD) drug. The therapy, which is set to enter a phase 1b study in the US in 2026, is being evaluated for its potential to “skip” over the faulty section of the RNA transcript for dystrophin.

submitted 1 day ago • 0 comments

Repurposing amlodipine, a common blood pressure drug, could provide a safer alternative to existing ADHD medicines 💊 Existing treatments can be associated with significant side effects. New research from the University of Surrey highlights the potential of amlodipine as a novel treatment.

submitted 2 days ago • 0 comments

New findings from University of North Carolina researchers show that a diabetic infection environment can drive the evolution of antibiotic resistance, contributing to the global AMR crisis. 🦠 Check out my full coverage of this research below.

submitted 9 days ago • 0 comments

Last week the US FDA approved Journavx, the first new class of pain management medicine to be approved in the US since 1998 💊 The approval is a huge step forward in the battle against opioid addiction. Further breakthroughs may be on the way in the form of a nanoparticle-delivered therapeutic.

submitted 20 days ago • 0 comments

Five years since the pandemic, long COVID remains an unsolved puzzle with no consensus on how to treat or prevent the condition 😷 However, researchers have begun to make strides in understanding the condition and in particular its impact on the brain.

submitted 22 days ago • 0 comments

New findings from the NIH RECOVER Initiative suggest that COVID-19 infection may be associated with an increased risk of chronic fatigue 🛌 These findings add to growing evidence that infections, including those caused by SARS-CoV-2, can lead to ME/CFS.

submitted 41 days ago • 0 comments

CRISPR screening of lab-grown “mini-guts” could lead to new treatments for inflammatory bowel disease 🧫 Identifying the underlying cause of IBD has been challenging, in part due to the difficulty in modeling the disease. However, a new organoid biobank could help us better understand the disease.

submitted 43 days ago • 0 comments

Recent headlines have been flooded with warnings of a possible pandemic threat following a surge in hMPV cases in China 🦠 But ✨thankfully ✨ experts seem to agree that the situation shouldn’t trigger fears of a larger pandemic threat given the nature of the virus.

submitted 50 days ago • 0 comments